Mosquito Saliva-Derived Vaccine Could Prevent Malaria, Dengue, Zika, And West Nile : MEDICINE & HEALTH : Science Times
The National Institute of Allergy And Infectious Diseases (NIAID) part of National Institute of Health (NIH) is conducting the trial. AGS-v, an investigational vaccine that is derived from mosquito's saliva is currently on study to target a broad range of mosquito transmitted diseases such as malaria, dengue, Zika, and West Nile. Like Us on FacebookAccording to Medical Xpress, NIAID has already launched Phase 1 clinical trial to test the vaccine. The single vaccine that could help prevent a bunch of diseases could be a monumental public health advance, stated by NIAID Director Anthony S. Fauci, M.D. The investigational vaccine consists of four synthetic proteins which are sourced from mosquito salivary glands.Mosquitoes spread viruses including Zika, yellow fever, dengue, West Nile virus, chikungunya and Japanese encephalitis. Related: How Mosquito Spit Might Affect Zika RiskThere's a good yellow fever vaccine, but it's in short supply. Government doctors have started testing a vaccine designed to protect against all diseases spread by mosquitoes, from Zika to malaria and yellow fever. And the same mosquitoes that spread yellow fever spread Zika, dengue and other viruses. The NIH is testing a new vaccine that targets mosquito saliva.
collected by :Lucy William
To follow all the new news about
No comments:
Post a Comment